Netherlands· NL-c52685d3767b

Ospolot 20 mg/ml suspensie voor oraal gebruik

A sultiame product containing sultiam, registered in Netherlands by Desitin Arzneimittel GmbH. The same ATC class is registered in 12 of our 19 countries.

ATC N03AX03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sultiamAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sultiame is registered in 12 of 19 countries.

Countries holding a registration under ATC N03AX03 (sultiame), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search sultiame products by name

Sultiame · ATC N03AX03

12 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sultiame costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sultiame · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$4.91

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SULTIAM
Manufacturer: Desitin Arzneimittel GmbH
Country: Netherlands (NL)
ATC code: N03AX03
ATC class: Sultiame
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
131687

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

12 interactions on record for sultiame.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sultiame against other medicines How interaction checks work

Sultiame · interactions on record

12 records

12 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sultiame in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sultiame products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Ospolot, Sultiam Neuraxpharm
Belgium · Ospolot
Czechia · Ospolot
Germany · Ospolot, Sultiam Neuraxpharm
Denmark · Ospolot, Ospolot-Tab
Estonia · Ospolot
Spain · Ospolot
Finland · Ospolot
United Kingdom (Northern Ireland) · Ospolot
Hungary · Ospolot
Ireland · Ospolot
Italy · Ospolot
Luxembourg · Ospolot
Norway · Ospolot
Poland · Sultiame Desitin
Portugal · Ospolot
Romania · Ospolot
Sweden · Ospolot
Slovakia · Ospolot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e391fcc1-ff68-427f-8a08-fd7068695403
GET /v1/drugs/e391fcc1-ff68-427f-8a08-fd7068695403?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131687_smpc.pdf",
  "strength": null,
  "atc_label": "Sultiame",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131687",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "AMMONIUMGLYCYRRHIZAAT",
    "ARABISCHE GOM (E 414)",
    "ARABISCHE GOM (E 414)",
    "DIKALIUMWATERSTOFFOSFAAT 0-WATER (E 340)",
    "DOCUSAATNATRIUM",
    "FOSFORZUUR (E 338)",
    "FRUCTOSE",
    "GLUCOSE 1-WATER",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MASKEERSMAAKSTOF",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
    "NATRIUMPROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROSE",
    "SUCRALOSE (E 955)",
    "SUCRALOSE (E 955)",
    "WATER, GEZUIVERD",
    "XANTHAANGOM (E 415)",
    "ZOETHEIDSMODULATORSMAAKSTOF",
    "ZWAVELDIOXIDE (E 220)"
  ],
  "substances": [
    "SULTIAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131687.pdf",
  "authorised_at": "2024/04/23",
  "procedure_number": "DE/H/7033/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131687",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sultiame.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console